Karen E. Fink
Impact in
- Genetics top 0.05%
- Glioma Diagnosis and Treatment
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 42
- Glioma Diagnosis and Treatment 42
-
- Cancer Genomics and Diagnostics 3
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Minesh P. Mehta (21 shared papers)Luís Souhami (6 shared papers)Jan C. Buckner (6 shared papers)David G Brachman (5 shared papers)Robert Brian Jenkins (4 shared papers)Gregory J. Cairncross (4 shared papers)EDWARD A. SHAW (4 shared papers)Timothy Francis Cloughesy (17 shared papers)
- Journals
- Neuro-Oncology (18 papers)Journal of Clinical Oncology (8 papers)Journal of Neuro-Oncology (5 papers)Clinical Cancer Research (5 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Karen E. Fink
64 papers receiving 11.6k citations
Karen E. Fink's Hit Papers
Peers
Comparison fields: 5 of 122
- Genetics 7.6k
- Cancer Research 1.9k
- Oncology 2.1k
- Immunology 1.6k
- Pulmonary and Respiratory Medicine 2.1k
Countries citing papers authored by Karen E. Fink
This map shows the geographic impact of Karen E. Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen E. Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen E. Fink more than expected).
Fields of papers citing papers by Karen E. Fink
This network shows the impact of papers produced by Karen E. Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen E. Fink. The network helps show where Karen E. Fink may publish in the future.
Co-authors
The 25 scholars most cited alongside Karen E. Fink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma Hit paper breakdown → | 2017 | 2013 |
| 2 | Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma Hit paper breakdown → | 2015 | 1045 |
| 3 | Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial Hit paper breakdown → | 2017 | 930 |
| 4 | Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402 Hit paper breakdown → | 2012 | 905 |
| 5 | A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse Hit paper breakdown → | 2000 | 817 |
| 6 | Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma Hit paper breakdown → | 2017 | 593 |
| 7 | 2006 | 587 | |
| 8 | First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma Hit paper breakdown → | 2018 | 457 |
| 9 | 2008 | 411 | |
| 10 | 2008 | 362 | |
| 11 | 2006 | 354 | |
| 12 | 2014 | 342 | |
| 13 | 2005 | 332 | |
| 14 | Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma Hit paper breakdown → | 2022 | 329 |
| 15 | 2019 | 225 | |
| 16 | 2006 | 216 | |
| 17 | 2015 | 209 | |
| 18 | 2020 | 153 | |
| 19 | 2003 | 133 | |
| 20 | 2006 | 131 |
About Karen E. Fink
Karen E. Fink is a scholar working on Genetics, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 66 papers that have together received 11.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (42 papers), Brain Metastases and Treatment (9 papers), Immunotherapy and Immune Responses (5 papers), Cancer Genomics and Diagnostics (3 papers), CAR-T cell therapy research (3 papers), Cancer Treatment and Pharmacology (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Genetics (7.6k citations), Cancer Research (1.9k citations), Oncology (2.1k citations), Immunology (1.6k citations) and Pulmonary and Respiratory Medicine (2.1k citations). Karen E. Fink has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Minesh P. Mehta, Luís Souhami, Jan C. Buckner, David G Brachman, Robert Brian Jenkins, Gregory J. Cairncross, EDWARD A. SHAW, Timothy Francis Cloughesy, Michael D. Prados and Susan Marina Chang. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Journal of Neuro-Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.